Revolution Medicines (RVMD) Tax Provisions (2020 - 2024)

Revolution Medicines' Tax Provisions history runs 4 years deep, the most recent figure standing at -$800000.0 for Q4 2024.

• In Q4 2024, Tax Provisions fell 119.09% year-over-year to -$800000.0; the TTM figure through Dec 2024 stood at -$800000.0 (down 346.91% YoY), while the FY2024 annual figure was -$800000.0, down 346.91% from the prior year.
• Tax Provisions for Q4 2024 stood at -$800000.0, down from $4.2 million in the prior quarter.
• The five-year high for Tax Provisions was $4.2 million in Q4 2023, with the low at -$3.9 million in Q3 2023.
• The 4-year median for Tax Provisions is -$200000.0 (2022), against an average of -$155875.0.
• Peak annual rise in Tax Provisions reached 4168.93% in 2023, while the deepest fall reached 1202.02% in 2023.
• Revolution Medicines' Tax Provisions stood at $362000.0 in 2020, then tumbled by 128.45% to -$103000.0 in 2022, then surged by 4168.93% to $4.2 million in 2023, then plunged by 119.09% to -$800000.0 in 2024.
• Business Quant data shows RVMD's Tax Provisions at -$800000.0 in Q4 2024, $4.2 million in Q4 2023, and -$3.9 million in Q3 2023.